Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)
Randomized studies to assess the efficacy of Mohs micrographic surgery in basal cell and squamous cell carcinomas are limited by methodological and ethical issues and a lack of long follow-up periods. This study presents the “real-life” results of a nationwide 7-years cohort on basal cell carcinoma...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/681dd3175485489f8fe0b520e3945bea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:681dd3175485489f8fe0b520e3945bea |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:681dd3175485489f8fe0b520e3945bea2021-11-24T13:53:59ZRisk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)10.2340/actadv.v101.5440001-55551651-2057https://doaj.org/article/681dd3175485489f8fe0b520e3945bea2021-11-01T00:00:00Zhttps://medicaljournalssweden.se/actadv/article/view/544https://doaj.org/toc/0001-5555https://doaj.org/toc/1651-2057Randomized studies to assess the efficacy of Mohs micrographic surgery in basal cell and squamous cell carcinomas are limited by methodological and ethical issues and a lack of long follow-up periods. This study presents the “real-life” results of a nationwide 7-years cohort on basal cell carcinoma and squamous cell carcinoma treated with Mohs micrographic surgery. A prospective cohort was conducted in 22 Spanish centres (from July 2013 to February 2020) and a multivariate analysis, including characteristics of patients, tumours, surgeries and follow-up, was performed. A total of 4,402 patients followed up for 12,111 patient-years for basal cell carcinoma, and 371 patients with 915 patient-years of follow-up for squamous cell carcinoma were recruited. Risk factors for recurrence included age, non-primary tumours and more stages or unfinished surgeries for both tumours, and immunosuppression for squamous cell carcinoma. Incidence rates of recurrence were 1.3 per 100 person-years for basal cell carcinoma (95% confidence interval 1.1–1.5) and 4.5 for squamous cell carcinoma (95% confidence interval 3.3–6.1), being constant over time (0–5 years). In conclusion, follow-up strategies should be equally intense for at least the first 5 years, with special attention paid to squamous cell carcinoma (especially in immunosuppressed patients), elderly patients, non-primary tumours, and those procedures requiring more stages, or unfinished surgeries. Alejandra Tomás-VelázquezOnofre Sanmartin-JiménezJoan R. GarcésManuel A. Rodríguez-PrietoVerónica Ruiz-SalasEsther de Eusebio-MurilloRomán Miñano-MedranoBegoña Escutia-MuñozÁngeles Flórez-MenéndezJuan L. Artola-IgarzaAlberto Alfaro-RubioPilar GilYolanda Delgado-JiménezJulia M. Sanchez-SchmidtIrati Allende-MarkixanaMaría L. Alonso-PachecoBeatriz García-BracamontePablo de la Cueva-DobaoRaquel Navarro-TejedorCristina Ciudad-BlancoLucía Carnero-GonzálezHugo Vázquez-VeigaNatividad Cano-MartínezEva Vilarrasa-RullPedro Sanchez-SambucetyJosé L. López-EstebaranzRafael Botella-EstradaBeatriz Gonzalez-SixtoAntonio Martorell-CalatayudVictoriano Morales-GordilloAgustí Toll-AbellóIzascun Ocerin-GuerraMatías Mayor-ArenalRicardo Suárez-FernándezLaura Sainz-GasparMiguel A. DescalzoIgnacio García-DovalPedro RedondoSociety for Publication of Acta Dermato-Venereologicaarticlebasal cell carcinomasquamous cell carcinomaMohs surgeryrecurrencerisk factorsDermatologyRL1-803ENActa Dermato-Venereologica, Vol 101, Iss 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
basal cell carcinoma squamous cell carcinoma Mohs surgery recurrence risk factors Dermatology RL1-803 |
spellingShingle |
basal cell carcinoma squamous cell carcinoma Mohs surgery recurrence risk factors Dermatology RL1-803 Alejandra Tomás-Velázquez Onofre Sanmartin-Jiménez Joan R. Garcés Manuel A. Rodríguez-Prieto Verónica Ruiz-Salas Esther de Eusebio-Murillo Román Miñano-Medrano Begoña Escutia-Muñoz Ángeles Flórez-Menéndez Juan L. Artola-Igarza Alberto Alfaro-Rubio Pilar Gil Yolanda Delgado-Jiménez Julia M. Sanchez-Schmidt Irati Allende-Markixana María L. Alonso-Pacheco Beatriz García-Bracamonte Pablo de la Cueva-Dobao Raquel Navarro-Tejedor Cristina Ciudad-Blanco Lucía Carnero-González Hugo Vázquez-Veiga Natividad Cano-Martínez Eva Vilarrasa-Rull Pedro Sanchez-Sambucety José L. López-Estebaranz Rafael Botella-Estrada Beatriz Gonzalez-Sixto Antonio Martorell-Calatayud Victoriano Morales-Gordillo Agustí Toll-Abelló Izascun Ocerin-Guerra Matías Mayor-Arenal Ricardo Suárez-Fernández Laura Sainz-Gaspar Miguel A. Descalzo Ignacio García-Doval Pedro Redondo Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery) |
description |
Randomized studies to assess the efficacy of Mohs micrographic surgery in basal cell and squamous cell carcinomas are limited by methodological and ethical issues and a lack of long follow-up periods. This study presents the “real-life” results of a nationwide 7-years cohort on basal cell carcinoma and squamous cell carcinoma treated with Mohs micrographic surgery. A prospective cohort was conducted in 22 Spanish centres (from July 2013 to February 2020) and a multivariate analysis, including characteristics of patients, tumours, surgeries and follow-up, was performed. A total of 4,402 patients followed up for 12,111 patient-years for basal cell carcinoma, and 371 patients with 915 patient-years of follow-up for squamous cell carcinoma were recruited. Risk factors for recurrence included age, non-primary tumours and more stages or unfinished surgeries for both tumours, and immunosuppression for squamous cell carcinoma. Incidence rates of recurrence were 1.3 per 100 person-years for basal cell carcinoma (95% confidence interval 1.1–1.5) and 4.5 for squamous cell carcinoma (95% confidence interval 3.3–6.1), being constant over time (0–5 years). In conclusion, follow-up strategies should be equally intense for at least the first 5 years, with special attention paid to squamous cell carcinoma (especially in immunosuppressed patients), elderly patients, non-primary tumours, and those procedures requiring more stages, or unfinished surgeries.
|
format |
article |
author |
Alejandra Tomás-Velázquez Onofre Sanmartin-Jiménez Joan R. Garcés Manuel A. Rodríguez-Prieto Verónica Ruiz-Salas Esther de Eusebio-Murillo Román Miñano-Medrano Begoña Escutia-Muñoz Ángeles Flórez-Menéndez Juan L. Artola-Igarza Alberto Alfaro-Rubio Pilar Gil Yolanda Delgado-Jiménez Julia M. Sanchez-Schmidt Irati Allende-Markixana María L. Alonso-Pacheco Beatriz García-Bracamonte Pablo de la Cueva-Dobao Raquel Navarro-Tejedor Cristina Ciudad-Blanco Lucía Carnero-González Hugo Vázquez-Veiga Natividad Cano-Martínez Eva Vilarrasa-Rull Pedro Sanchez-Sambucety José L. López-Estebaranz Rafael Botella-Estrada Beatriz Gonzalez-Sixto Antonio Martorell-Calatayud Victoriano Morales-Gordillo Agustí Toll-Abelló Izascun Ocerin-Guerra Matías Mayor-Arenal Ricardo Suárez-Fernández Laura Sainz-Gaspar Miguel A. Descalzo Ignacio García-Doval Pedro Redondo |
author_facet |
Alejandra Tomás-Velázquez Onofre Sanmartin-Jiménez Joan R. Garcés Manuel A. Rodríguez-Prieto Verónica Ruiz-Salas Esther de Eusebio-Murillo Román Miñano-Medrano Begoña Escutia-Muñoz Ángeles Flórez-Menéndez Juan L. Artola-Igarza Alberto Alfaro-Rubio Pilar Gil Yolanda Delgado-Jiménez Julia M. Sanchez-Schmidt Irati Allende-Markixana María L. Alonso-Pacheco Beatriz García-Bracamonte Pablo de la Cueva-Dobao Raquel Navarro-Tejedor Cristina Ciudad-Blanco Lucía Carnero-González Hugo Vázquez-Veiga Natividad Cano-Martínez Eva Vilarrasa-Rull Pedro Sanchez-Sambucety José L. López-Estebaranz Rafael Botella-Estrada Beatriz Gonzalez-Sixto Antonio Martorell-Calatayud Victoriano Morales-Gordillo Agustí Toll-Abelló Izascun Ocerin-Guerra Matías Mayor-Arenal Ricardo Suárez-Fernández Laura Sainz-Gaspar Miguel A. Descalzo Ignacio García-Doval Pedro Redondo |
author_sort |
Alejandra Tomás-Velázquez |
title |
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery) |
title_short |
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery) |
title_full |
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery) |
title_fullStr |
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery) |
title_full_unstemmed |
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery) |
title_sort |
risk factors and rate of recurrence after mohs surgery in basal cell and squamous cell carcinomas: a nationwide prospective cohort (regesmohs, spanish registry of mohs surgery) |
publisher |
Society for Publication of Acta Dermato-Venereologica |
publishDate |
2021 |
url |
https://doaj.org/article/681dd3175485489f8fe0b520e3945bea |
work_keys_str_mv |
AT alejandratomasvelazquez riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT onofresanmartinjimenez riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT joanrgarces riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT manuelarodriguezprieto riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT veronicaruizsalas riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT estherdeeusebiomurillo riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT romanminanomedrano riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT begonaescutiamunoz riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT angelesflorezmenendez riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT juanlartolaigarza riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT albertoalfarorubio riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT pilargil riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT yolandadelgadojimenez riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT juliamsanchezschmidt riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT iratiallendemarkixana riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT marialalonsopacheco riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT beatrizgarciabracamonte riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT pablodelacuevadobao riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT raquelnavarrotejedor riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT cristinaciudadblanco riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT luciacarnerogonzalez riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT hugovazquezveiga riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT natividadcanomartinez riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT evavilarrasarull riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT pedrosanchezsambucety riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT josellopezestebaranz riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT rafaelbotellaestrada riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT beatrizgonzalezsixto riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT antoniomartorellcalatayud riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT victorianomoralesgordillo riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT agustitollabello riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT izascunoceringuerra riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT matiasmayorarenal riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT ricardosuarezfernandez riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT laurasainzgaspar riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT migueladescalzo riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT ignaciogarciadoval riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery AT pedroredondo riskfactorsandrateofrecurrenceaftermohssurgeryinbasalcellandsquamouscellcarcinomasanationwideprospectivecohortregesmohsspanishregistryofmohssurgery |
_version_ |
1718415051657838592 |